Ste&P Research LLC
Milpitas, CA Doing business as Seqpal
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
-
- 325414 Biological Product (except Diagnostic) Manufacturing
- 339999 All Other Miscellaneous Manufacturing
- 541380 Testing Laboratories and Services
- 541690 Other Scientific and Technical Consulting Services
- 541713 Research and Development in Nanotechnology
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 1605 S Main St # 120, Milpitas, CA 95035, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $23,370 |
| FY2023 | $29,800 |
Contract awards
Similar vendors
About the company
Ste&P Research LLC, doing business as Seqpal, is a self-certified small disadvantaged business registered to receive federal government awards since July 2018. The company operates as a partnership or limited liability partnership and is classified as a for-profit organization. Seqpal specializes in providing genomic sequencing services to federal agencies, particularly focusing on whole exome sequencing and analysis of DNA samples. Their expertise appears to be in processing and sequencing genomic data for research purposes, primarily supporting studies related to drug responses and potential adverse effects.
Seqpal has consistently secured federal contract awards from the Food and Drug Administration (FDA), a division of the Department of Health and Human Services. Their recent contracts have involved sequencing genomic DNA samples for various research protocols. In February 2024, they were awarded a $70,110 firm fixed price purchase order to sequence 95 genomic DNA samples from drug-induced liver injury patients, supporting a study to identify genetic and non-genetic factors associated with individual susceptibility to drug toxicity. Previous awards in January 2023 and June 2022, valued at $29,800 and $25,026 respectively, also involved whole exome sequencing of genomic DNA samples. These contracts were awarded without set-aside designations, despite Seqpal's status as a small disadvantaged business. The work performed by Seqpal contributes to the FDA's efforts in understanding genetic factors influencing drug responses and ensuring drug safety.
Quick answers
Is Ste&P Research LLC registered in SAM.gov?
Yes. Ste&P Research LLC's SAM.gov registration is active through November 19, 2026.
What is Ste&P Research LLC's CAGE code?
Ste&P Research LLC's CAGE code is 85PT8, and its Unique Entity ID (UEI) is J5J8KBH3AQ34.
How much has Ste&P Research LLC received in federal contracts?
Federal contracts obligated $53,170 to Ste&P Research LLC in fiscal years 2023 through 2027.
What is Ste&P Research LLC's most recent federal award?
Ste&P Research LLC's most recent federal contract award is The division of bioinformatics and biostatistics (DBB) requires service to sequence 95 genomic deoxyribonucleic acid… (75F40124P00059), from Food and Drug Administration, on February 6, 2024.
On GovTribe
See Ste&P Research LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors